396 related articles for article (PubMed ID: 25174598)
21. Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis.
Zhang C; Sun A; Zhang P; Wu C; Zhang S; Fu M; Wang K; Zou Y; Ge J
Diabetes Res Clin Pract; 2010 Feb; 87(2):211-8. PubMed ID: 19853947
[TBL] [Abstract][Full Text] [Related]
22. The aspirin controversy in primary prevention.
Raju NC; Eikelboom JW
Curr Opin Cardiol; 2012 Sep; 27(5):499-507. PubMed ID: 22874127
[TBL] [Abstract][Full Text] [Related]
23. [Aspirin in primary prevention of cardiovascular diseases: how to balance risks and benefits].
De Caterina R; Orlando D; Berti V; Coccheri S
G Ital Cardiol (Rome); 2012; 13(7-8):494-502. PubMed ID: 22781376
[TBL] [Abstract][Full Text] [Related]
24. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881
[TBL] [Abstract][Full Text] [Related]
25. Aspirin and primary cardiovascular prevention. Uncertain balance between benefits and risks.
Prescrire Int; 2010 Nov; 19(110):258-61. PubMed ID: 21284360
[TBL] [Abstract][Full Text] [Related]
26. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
Morimoto T; Fukui T; Lee TH; Matsui K
Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702
[TBL] [Abstract][Full Text] [Related]
27. Primary prevention of cardiovascular complications in type II diabetes patients using aspirin: a complicated tale.
Schmidt BM; Arora R
Am J Ther; 2013; 20(3):275-8. PubMed ID: 19797944
[TBL] [Abstract][Full Text] [Related]
28. Which Aspirin Dose and Preparation Is Best for the Long-Term Prevention of Cardiovascular Disease and Cancer? Evidence From a Systematic Review and Network Meta-Analysis.
Lotrionte M; Biasucci LM; Peruzzi M; Frati G; Giordano A; Biondi-Zoccai G
Prog Cardiovasc Dis; 2016; 58(5):495-504. PubMed ID: 26851562
[TBL] [Abstract][Full Text] [Related]
29. Low-dose aspirin and upper gastrointestinal bleeding in primary versus secondary cardiovascular prevention: a population-based, nested case-control study.
Lin KJ; De Caterina R; García Rodríguez LA
Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):70-7. PubMed ID: 24254886
[TBL] [Abstract][Full Text] [Related]
30. A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular disease.
Lamotte M; Annemans L; Evers T; Kubin M
Pharmacoeconomics; 2006; 24(2):155-69. PubMed ID: 16460136
[TBL] [Abstract][Full Text] [Related]
31. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
Sandler RS
Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
[TBL] [Abstract][Full Text] [Related]
32. AAA- a further step towards a moratorium for aspirin in the primary prevention.
Minar E
Vasa; 2010 May; 39(2):119-122. PubMed ID: 20521434
[No Abstract] [Full Text] [Related]
33. Dose of aspirin in the treatment and prevention of cardiovascular disease: current and future directions.
Hennekens CH; Sechenova O; Hollar D; Serebruany VL
J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):170-6. PubMed ID: 17056829
[TBL] [Abstract][Full Text] [Related]
34. Low-dose aspirin for everyone?
Johns Hopkins Med Lett Health After 50; 2002 Oct; 14(8):4-5. PubMed ID: 12425276
[No Abstract] [Full Text] [Related]
35. Aspirin in primary prevention of cardiovascular disease in the elderly.
Galli M; Andreotti F; D'Amario D; Vergallo R; Montone RA; Porto I; Crea F
Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):326-327. PubMed ID: 31504373
[No Abstract] [Full Text] [Related]
36. Predicting Bleeding Risk to Guide Aspirin Use for the Primary Prevention of Cardiovascular Disease: A Cohort Study.
Selak V; Jackson R; Poppe K; Wu B; Harwood M; Grey C; Pylypchuk R; Mehta S; Kerr A; Wells S
Ann Intern Med; 2019 Mar; 170(6):357-368. PubMed ID: 30802900
[TBL] [Abstract][Full Text] [Related]
37. Aspirin in the primary prevention of cardiovascular disease.
Hennekens CH; Buring JE
Cardiol Clin; 1994 Aug; 12(3):443-50. PubMed ID: 7805078
[TBL] [Abstract][Full Text] [Related]
38. Aspirin Efficacy in Primary Prevention: A Meta-analysis of Randomized Controlled Trials.
Barbarawi M; Kheiri B; Zayed Y; Gakhal I; Al-Abdouh A; Barbarawi O; Rashdan L; Rizk F; Bachuwa G; Alkotob ML
High Blood Press Cardiovasc Prev; 2019 Aug; 26(4):283-291. PubMed ID: 31280451
[TBL] [Abstract][Full Text] [Related]
39. [Primary prevention of cardiovascular disease with acetylsalicylic acid: in high-risk patients].
Kappelle LJ
Ned Tijdschr Geneeskd; 2005 Apr; 149(16):853-4. PubMed ID: 15868987
[TBL] [Abstract][Full Text] [Related]
40. Aspirin for primary prevention of cardiovascular disease?
Drug Ther Bull; 2009 Nov; 47(11):122-5. PubMed ID: 19887685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]